MedPath

The Impact of Botox® During Robotic Rehabilitation of the Wrist Following Stroke

Phase 1
Completed
Conditions
Stroke
Interventions
Other: Botox®
Other: saline solution
Registration Number
NCT01088230
Lead Sponsor
New York Presbyterian Hospital
Brief Summary

The purpose of this study is to see whether treating subjects for wrist rehabilitation following stroke with Botox® and robotic therapy is more effective than treatment with robotic therapy alone and no Botox®.

Detailed Description

This study will explore new ways to facilitate rehabilitation of wrist function after stroke. One of the challenges of recovery is muscle stiffness or excessive muscle tone that often limits exercise or therapy progress. Taking this into account, the investigators propose treating the wrist and forearm with a combination of a one-time Botox® injection and a 6-week robotic therapy protocol to maximize recovery.

Botox® is a drug that is injected directly into a muscle to temporarily relax the muscle. Botox® is commonly used to decrease muscle tone in tight muscles in the stroke population. Robotics therapy provides highly repetitive mass practice with visual and haptic feedback.

Subjects will be randomized to two groups. Group A will receive the Botox® injection and group B will receive a placebo saline injection. Both groups will receive the same robotics therapy protocol. Subjects and investigators will be blinded to group assignment. The investigators would like to know if there are trends between groups in a variety of outcome measures depending on what intervention they received. The investigators predict that the treatment group will have better results than the control group on the Fugl Meyer, our primary outcome measure. The investigators hope the results of this pilot study will guide development of a larger clinical trial.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • > 6 months post-stroke
  • Single stroke
  • Ashworth Scale of > 2 but < 4 for wrist flexors and pronators
  • Able to follow multiple step directions
  • Completed all active occupational therapy
  • Motor strength > 1/5 at the wrist extension and supination
  • Passive ROM of 0-45 degrees at wrist flexion and extension, 0-20 degrees at radial deviation, 0-20 degrees at ulnar deviation, 0-45 degrees at pronation and supination
  • No Botox® injection in the wrist/forearm muscles for at least 12 months
  • Naïve to robotics study protocol
Exclusion Criteria
  • Joint contracture and wrist or forearm

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Botox®Botox®this group will receive an injection of botox in the wrist flexors and forearm pronators
Salinesaline solutionThis group will receive an injection of saline solution in the same muscle groups as the treatment group (wrist flexors and pronators).
Primary Outcome Measures
NameTimeMethod
Change scores on Fugl Meyer- Upper Extremity Sectionat baseline and discharge

The Fugl Meyer assess quality of movement of the limb at an impairment level.

Secondary Outcome Measures
NameTimeMethod
Change on kinematic analysisbefore injection and one week post injection

Kinematic information is recorded during administration of the assessment mode of the InMotion 3 wrist robotic device. Movements of the wrist (flexion,extension,ulnar/radial deviation) and forearm (pronation, supination)are recorded for subsequent analysis. Kinematic parameters such as smoothness, position and velocity of movement are examined pre and post injection. The information is extracted from the robotics device and analyzed via computer programs.

Trial Locations

Locations (1)

New York Presbyterian Hospital- Weill Cornell campus

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath